Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study

Journal of Diabetes and its Complications 2026

View at publisher
Authors: Anderson Matheus Pereira da Silva, Leonardo Januário Campos Cardoso, Sávio Batista, Ocílio Ribeiro Gonçalves, Thiago Paranhos, Ivan Petterson Santana Teixeira, Pedro Duarte Guimarães, Beatriz Espinosa Franco, Henrique Cal, João Eduardo Nunes Salles, George Perry, Poul F. Høilund-Carlsen
+1 more Diogo Haddad Santos
DOI: 10.1016/j.jdiacomp.2026.109306
Cited by: 2
References: 37

Fields of Study & Subjects

Diabetes Treatment and Management Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments

Publication details

Journal / source
Journal of Diabetes and its Complications
Publisher
Elsevier BV
Volume
40
Issue
5
Pages
109306–109306
Publication date
25 February 2026
Language
EN